Identification of structural aberrations in cancer by SNP array analysis.

Identification of structural aberrations in cancer by SNP array analysis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Identification of structural aberrations in cancer by SNP array analysis. Abstract Text:

Stefan Heinrichs,A Thomas Look,Stefan Heinrichs,A Thomas Look,Stefan Heinrichs,A Thomas Look,

ABSTRACT : Recent studies using single-nucleotide polymorphism arrays have pinpointed novel oncogenes and tumor suppressors involved in specific types of human cancers.

Identification of structural aberrations in cancer by SNP array analysis. Publishing Authors By Initials

S Heinrichs,AT Look,S Heinrichs,AT Look,S Heinrichs,AT Look,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Identification of structural aberrations in cancer by SNP array analysis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Genome biology

VOLUME: 8

Page Numbers: 219

Journal Abbreviation: Genome Biol.

ISSN: 1465-6914

DAY: 16

MONTH: 01

YEAR: 2007

Identification of structural aberrations in cancer by SNP array analysis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100960660

Identification of structural aberrations in cancer by SNP array analysis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Identification of structural aberrations in cancer by SNP array analysis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Identification of structural aberrations in cancer by SNP array analysis.

AFFILIATION: Dana-Farber Cancer Institute, Department of Pediatric Oncology, Binney Street, Boston, MA 02215, USA,.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Genome Biol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Identification of structural aberrations in cancer by SNP array analysis Related Publications

• A creative response meets community need/enriches hospital.
• Activating mutations in ALK provide a therapeutic target in neuroblastoma.
• Acute lymphoblastic leukaemia.
• Chk1 Suppresses a Caspase-2 Apoptotic Response to DNA Damage that Bypasses p53, Bcl-2, and Caspase-3.
• Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
• Combined source-detector response characteristics.
• Dominant-interfering C/EBPalpha stimulates primitive erythropoiesis in zebrafish.
• FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.
• Identification of structural aberrations in cancer by SNP array analysis.
• Inhibition of Jak1-dependent signal transduction in airway epithelial cells infected with adenovirus.
• Mechanisms of transcription factor deregulation in lymphoid cell transformation.
• Myelopoiesis in the zebrafish, Danio rerio.
• NOTCH and PI3K-AKT pathways intertwined.
• Type 2 diabetes in native Hawaiians and Pacific Islanders in Hawaii.